Related Experiment Video
Updated: May 2, 2026

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.9K
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years
Regina Schlaeger1, Christian Schindler2, Leticia Grize2
1Department of Neurology, University Hospital Basel, Switzerland.
Summary
Combined evoked potential (EP) measures effectively predict long-term multiple sclerosis (MS) disability. This finding aids in understanding disease progression and patient outcomes over two decades.
Area of Science:
- Neuroscience
- Clinical Neurology
- Biomedical Engineering
Background:
- Predicting multiple sclerosis (MS) disability is challenging due to complex pathophysiological and adaptive factors.
- Identifying reliable predictors is crucial for managing MS progression.
Purpose of the Study:
- To determine if combined evoked potential (EP) measures can predict MS disability over a 20-year period.
- To establish the predictive value of baseline EP data for long-term MS outcomes.
Main Methods:
- Twenty-eight patients with clinically definite MS underwent combined visual and motor EP testing and Expanded Disability Status Scale (EDSS) assessments.
- Cranial magnetic resonance imaging (MRI) was performed, and EDSS was reassessed at 14 and 20 years.
- Multivariable regression analysis was used to evaluate the predictive relationship between baseline EP latencies and long-term EDSS scores.
Main Results:
- The sum of z-transformed EP latencies at baseline (s-EPT0) significantly correlated with EDSS at 20 years (EDSST5) and change in EDSS (ΔEDSST5-T0).
- A prediction model incorporating therapy, age, and s-EPT0 explained 58% of the variance in EDSST5 (R²=0.58), with an ROC curve area of 0.89.
- Neither baseline EDSS, T2-lesion, nor gadolinium-enhancing lesion counts improved the prediction of long-term disability.
Conclusions:
- Combined EP measures demonstrate significant potential as predictors of long-term disability in multiple sclerosis.
- These findings support the utility of EP assessments in monitoring MS progression and informing patient management strategies.

